ArticleJournal of translational medicine2025

KBTBD11 suppresses hepatocellular carcinoma by targeting ENO1-mediated glycolysis.

Yixuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.